Kwok Chi Lam

A Randomized Phase III Study of Doxorubicin Versus Cisplatin/Interferon α-2b/Doxorubicin/Fluorouracil (PIAF) Combination Chemotherapy for Unresectable Hepatocellular Carcinoma

Winnie Yeo, Tony Mok, Benny Zee et al. · JNCI Journal of the National Cancer Institute · 2005 · 589 citations · Full text

Medicine, Oncology, Pharmacology +14

Lamivudine for the Prevention of Hepatitis B Virus Reactivation in Hepatitis B s-Antigen Seropositive Cancer Patients Undergoing Cytotoxic Chemotherapy

Winnie Yeo, Paul K.S. Chan, Wing Ming Ho et al. · Journal of Clinical Oncology · 2004 · 260 citations · Full text

Medicine, Oncology, Pharmacology +14

New Utility of an Old Marker: Serial α-Fetoprotein Measurement in Predicting Radiologic Response and Survival of Patients With Hepatocellular Carcinoma Undergoing Systemic Chemotherapy

Stephen L. Chan, Frankie Mo, Philip J. Johnson et al. · Journal of Clinical Oncology · 2008 · 253 citations

Medicine, Oncology, Radiology +17

Hepatitis B virus reactivation in breast cancer patients receiving cytotoxic chemotherapy: A prospective study

Winnie Yeo, Paul K.S. Chan, Pun Hui et al. · Journal of Medical Virology · 2003 · 203 citations

Medicine, Infectious Diseases, Oncology +10

A multicenter phase II trial of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP, Triapine®) and gemcitabine in advanced non-small-cell lung cancer with pharmacokinetic evaluation using peripheral blood mononuclear cells

Brigette Ma, Boon Cher Goh, Eng Huat Tan et al. · Investigational New Drugs · 2007 · 159 citations

Medicine, Pharmacokinetics, Pharmacology +12